CRDF institutional holders
CARDIFF ONCOLOGY INC · 13F, 2026Q2
| Managers holding | 104 |
|---|
| Shares held | 18,788,015 |
|---|
| Reported value | $24.3m |
|---|
| Quarter flows | 20 new, 35 added, 26 trimmed, 33 exited |
|---|
Top 25 holders
| Manager | Shares | Value | % of manager's 13F |
|---|
| Laurion Capital Management LP | 3,098,299 | $4.0m | 0.1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,895,592 | $3.8m | 0.0% |
| Pfizer Inc | 2,411,575 | $3.0m | 1.8% |
| FRANKLIN RESOURCES INC | 1,205,803 | $1.6m | 0.0% |
| BlackRock, Inc. | 972,873 | $1.3m | 0.0% |
| BLAIR WILLIAM & CO/IL | 912,513 | $1.2m | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 820,062 | $1.1m | 0.0% |
| UBS Group AG | 638,699 | $830,309 | 0.0% |
| JANE STREET GROUP, LLC | 607,900 | $790,270 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 410,602 | $533,783 | 0.0% |
| AQR CAPITAL MANAGEMENT LLC | 346,353 | $450,260 | 0.0% |
| STATE STREET CORP | 331,395 | $430,814 | 0.0% |
| HRT FINANCIAL LP | 272,786 | $354,000 | 0.0% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 247,474 | $321,716 | 0.0% |
| MORGAN STANLEY | 246,095 | $319,924 | 0.0% |
| BNP PARIBAS FINANCIAL MARKETS | 228,461 | $296,999 | 0.0% |
| X-Square Capital, LLC | 205,700 | $267,000 | 0.1% |
| GSA CAPITAL PARTNERS LLP | 173,274 | $225,000 | 0.0% |
| MARSHALL WACE, LLP | 162,214 | $210,879 | 0.0% |
| Bank of New York Mellon Corp | 161,689 | $210,196 | 0.0% |
| NORTHERN TRUST CORP | 152,875 | $198,738 | 0.0% |
| Avestar Capital, LLC | 136,145 | $176,989 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 134,517 | $174,872 | 0.0% |
| Assenagon Asset Management S.A. | 134,462 | $174,800 | 0.0% |
| Qube Research & Technologies Ltd | 125,550 | $163,215 | 0.0% |
Every holder, line by line, and the full history since 2013: yf.Client().holders("CRDF"). CRDF price history · All 13F data
Get a free API keySee history bundlesDownload free samples